This website uses cookies. By continuing you are agreeing to our privacy policy.

Johnathan Whetstine, Ph.D.

Johnathan Whetstine
Fox Chase Cancer Center
Chromatin Factors Impacting Lung Cancer
Lung Cancer Discovery Award
Funded by the American Lung Association of the Northeast

Cancers occur when genetic mutations build up in critical genes, specifically those that control cell growth and division or the repair of damaged DNA. These changes allow cells to grow and divide uncontrollably to form a tumor. Abnormal duplication of genes increases lung cancer-associated risk and drug resistance. Gene amplification is a frequent genetic abnormality in cancer cells and consists of multiple extra copies of a region of DNA. We have discovered eight enzymes that lead to genetic changes linked to drug resistance in lung cancer. We will investigate how these eight enzymes lead to cancer gene amplification in lung cancer. This research will uncover novel biomarkers in lung cancer and identify new drug targets to tackle aggressive, drug-resistant lung cancer.

Red button with telephone
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
Red button of two hand prints
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

Button of turquoise LUNG FORCE swirl
What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.